SUMMARY A patient with severe late onset primary hypogammaglobulinaemia developed coeliac disease. The case illustrates that coeliac disease can occur in the virtual absence of local antibody production by plasma cells in the mucosa of the small bowel. Furthermore, our inability to demonstrate specific cellular immunity to a subfraction of gluten raises doubts about the relevance of immunological reactions in the pathogenesis of coeliac disease.
There are two main hypotheses to explain the aetiology of coeliac disease. Bronstein et al. ' suggested that the disease was caused by enzymatic failure to degrade gluten with a consequent production of peptides which were toxic to the small intestinal epithelial cells. This hypothesis does not exclude a secondary role for immunological reactions in the pathogenesis of the condition. The currently more favoured view2 is that the intestinal lesion is initiated and perpetuated by an immunological reaction. This is supported by the finding of numerous plasma cells in the intestinal lesions of coeliac disease.3 Cellular immune mechanisms may also play a part in causing damage to the mucosa, and it has been suggested that the lymphocytes of coeliac patients may be sensitised to certain subfractions of gluten.465 The strong association with the HLA-DW3 histocompatibility antigen is further evidence that the disease has an immunological basis.
The presence of complement and its breakdown products in the mucosal lesions of coeliac patients suggests that the damage is mediated by an Arthus reaction.6 The specificity of the antibody involved is not known but is presumed to be directed against a component of gluten. However, the case described here shows that antibody mediated reactions are not essential in the pathogenesis of coeliac disease.
Case report
LT developed pneumonia when aged 43 years, having previously shown no undue susceptibility to Received for publication 12 September 1980 infections. After this he suffered with recurrent episodes of bronchitis and sinusitis. Hypogammaglobulinaemia was diagnosed at 53 years and he was treated with regular weekly injections of gammaglobulin. Thereafter, he did well and only had one or two attacks of bronchitis requiring antibiotics during the subsequent 15 years.
For the past 25 years he has suffered with mild recurrent eczematous dermatitis on the fingers and seborrhoeic dermatitis in the groins. At the age of 55 years he developed a small patch of vitiligo over the sternum. During the first few months of 1978 he experienced a number of anaphylactic reactions to his gammaglobulin injections, although he has had no reactions for the past two years.
In 1974 (aged 63 years) he began passing three to four steatorrhoeic motions a day, although he was not losing weight. Physical examination at this time showed no abnormality and the following investigations confirmed malabsorption: the five day faecal fat collection on a 100 g fat diet per day was 9.3 g/ day. The red cell folate was 76 ng/ml (normal 145-450 ng/ml) and the peripheral blood film showed a mild macrocytosis. 
Skini tests
An intradermal skin test with 01 ml of the Oxford B2 fraction, together with an appropriate control, was performed as recommended by Anand et al.10 At six hours, the B2 fraction produced an area of erythema of 15 mm diameter which then gradually faded and disappeared by 24 hours. The control test site showed a 3 mm reaction at six hours and then faded rapidly. The skin tests were repeated one month later when the B2 fraction gave a response of 10 mm in diameter, but this time biopsies of the test areas for both the B2 fraction and the control were obtained at six hours. The histology showed an inflammatory reaction, with mononuclear cells and neutrophils in both the control and B2 fraction test site. There was also no significant difference in the number of basophils present in both the control and the test site and immunofluorescent studies showed no accumulation of C3.
Discussion
Coeliac disease has been previously suspected in a few patients with primary hypogammaglobulinaemia, but has never been satisfactorily confirmed by showing a relapse on a normal diet.8 9 The necessary criteria for the diagnosis of gluten enteropathy have been fulfilled in this patient by demonstrating both histological and clinical improvement after gluten withdrawal, followed by relapse on a normal diet, and then improvement again after gluten withdrawal. Apart from an occasional IgM-containing cell, immunofluorescent and immunoperoxidase staining together with electronmicroscopy failed to demonstrate the presence of immunoglobulin containing plasma cells in jejunal biopsies from this patient. It is difficult to interpret the negative findings after the gluten challenge and we might have seen changes if we had waited longer than 48 hours before repeating the jejunal biopsy.
Although Anand et al.10 found a good correlation between coeliac disease and positive skin tests to the B2 fraction of gluten, the interpretation of the skin test in this patient is not straightforward, as positive skin tests are also associated with other inflammatory bowel disorders." Although the timing of the skin reaction in our patient was consistent with an Arthus reaction, this was not confirmed by the histology and immunofluorescent findings.
It has been suggested that the increase in epithelial lymphocytes means that the mucosal damage could be mediated by a cellular immune reaction.'2 Intraepithelial lymphocyte counts were raised in our patient during relapse. However, Guix et al.13 suggest that this has little significance in the pathogenesis, as, in absolute terms, the number of intraepithelial lymphocytes does not alter during relapse and remission. Moreover 
